MARGOLIN YAEL 4
4 · POINT Biopharma Global Inc. · Filed Jun 6, 2022
Insider Transaction Report
Form 4
MARGOLIN YAEL
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-02+25,614→ 25,614 totalExercise: $8.31Exp: 2028-06-02→ Common Stock (25,614 underlying)
Footnotes (1)
- [F1]The option will vest 100% on the first anniversary of the grant date.